DANIELLE DU FRESNE: Open Payments
NPI 1124750286 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 21 payments from 10 companies in 2025. Trend: 2023 $660 · 2024 $931 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $89 |
| ABBVIE INC. | 4 | $87 |
| Novo Nordisk Inc | 4 | $79 |
| Amgen Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| PhotoniCare Inc | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: ZEPBOUND, Ozempic, VRAYLAR, FARXIGA, EVENITY, MOUNJARO, QULIPTA, OtoSight Middle Ear Scope.
Industry payments across NC — which companies pay providers there.
